For more than one century, the Edmond de Rothschild Foundations have supported scientific and medical research, particularly in the fields of ophthalmology and neuroscience.
In France alone, cataracts occur in one in five people over age 65. Macular degeneration affects 1.5 million people. And 400,000 people have glaucoma without being aware of it. Visual impairment represents a genuine obstacle to social inclusion. Blindness is a truly critical problem.
In addition, more and more individuals are affected by multiple neurological disorders, compounded by the phenomenon of aging especially in Western countries. In 1886, Baron Adolphe de Rothschild was a visionary who expressed his desire to create a hospital facility specialized in ophthalmology and neurology.
The Fondation Ophtalmologique Adolphe de Rothschild, a leading Parisian hospital, boasts cutting-edge technology and first-rate medical and surgical teams.
The Foundation is internationally recognized for its pecialization in head and neck disorders. It ranks high for the treatment of cataracts, myopia, cerebral aneurysm, treatment of retinal disorders and glaucoma.
The Edmond de Rothschild Foundations continue to uphold a tradition of excellence in medical research.
The Foundations support both fundamental research and clinical applications. The advancement of scientific knowledge enables us to develop useful applications that benefit patients’ recovery.
We also seek to promote greater synergy through international partnerships among scientific centers: through cooperation among hospitals to facilitate studies as well as patient care and recovery and through a special emphasis on the many ways in which scientific research, social impact and economic sustainability are intertwined.